Molecular Mechanisms Underlying Oncogenic RET Fusion in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Molecular Mechanisms Underlying Oncogenic RET Fusion in Lung Adenocarcinoma

Published:2014-05 Issue:5 Volume:9 Page:622-630
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Mizukami Tatsuji,Shiraishi Kouya,Shimada Yoko,Ogiwara Hideaki,Tsuta Koji,Ichikawa Hitoshi,Sakamoto Hiromi,Kato Mamoru,Shibata Tatsuhiro,Nakano Takashi,Kohno Takashi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. RET, ROS1 and ALK fusions in lung cancer;Takeuchi;Nat Med,2012

2. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies;Lipson;Nat Med,2012

3. KIF5B-RET fusions in lung adenocarcinoma;Kohno;Nat Med,2012

4. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing;Ju;Genome Res,2012

5. A patient with lung adenocarcinoma and RET fusion treated with vandetanib;Gautschi;J Thorac Oncol,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche;Proceedings of the National Academy of Sciences;2024-05-28

2. RET Fusion Testing in Patients With NSCLC: The RETING Study;JTO Clinical and Research Reports;2024-04

3. Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance;Drug Resistance Updates;2024-01

4. Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs);Cells;2023-12-15

5. Tissue-Agnostic Cancer Therapy Approvals;Surgical Oncology Clinics of North America;2023-12